{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:35:46Z","timestamp":1791938146409,"version":"4.3.4"},"reference-count":146,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.kint.2021.04.016","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T12:19:20Z","timestamp":1619612360000},"page":"536-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation"],"prefix":"10.1016","volume":"100","author":[{"given":"Claudio","family":"Ponticelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Campise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2021.04.016_bib1","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/01.ASN.0000019641.41496.1E","article-title":"Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study","volume":"13","author":"Longenecker","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"suppl 76","key":"10.1016\/j.kint.2021.04.016_bib2","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1046\/j.1523-1755.2000.07618.x","article-title":"Pathophysiology of cardiovascular disease in hemodialysis patients","volume":"58","author":"Meeus","year":"2000","journal-title":"Kidney Int"},{"issue":"suppl 3","key":"10.1016\/j.kint.2021.04.016_bib3","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transpl"},{"key":"10.1016\/j.kint.2021.04.016_bib4","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1046\/j.1523-1755.2002.00677.x","article-title":"Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study","volume":"62","author":"Sarnak","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","article-title":"Biomarkers of inflammation and progression of chronic kidney disease","volume":"68","author":"Tonelli","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib6","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1600-6143.2011.03466.x","article-title":"Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation","volume":"11","author":"De Vries","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2021.04.016_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ki.2014.304","article-title":"Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation","volume":"87","author":"Debout","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ki.2014.359","article-title":"The impact of cold ischemia time on renal transplant outcome","volume":"87","author":"Ponticelli","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCRESAHA.117.306340","article-title":"Determinants and outcomes of accelerated arteriosclerosis: major impact of circulating antibodies","volume":"117","author":"Loupy","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2021.04.016_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/TP.0000000000002889","article-title":"HLA class ii antibodies at the time of kidney transplantation and cardiovascular outcome: a retrospective cohort study","volume":"104","author":"Malfait","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2021.04.016_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fped.2020.00017","article-title":"Circulating de novo donor specific antibodies and carotid intima-media thickness in pediatric kidney transplant recipients, a pilot study","volume":"8","author":"Sgambat","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.kint.2021.04.016_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41423-019-0226-0","article-title":"Primed macrophages directly and specifically reject allografts","volume":"17","author":"Chu","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.kint.2021.04.016_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imr.12146","article-title":"Inflammatory triggers of acute rejection of organ allografts","volume":"258","author":"Mori","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2021.04.016_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2021.04.016_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","article-title":"Mechanisms of rejection: current perspectives","volume":"93","author":"Wood","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2021.04.016_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrcardio.2015.169","article-title":"Regulatory T cells in cardiovascular diseases","volume":"13","author":"Meng","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.kint.2021.04.016_bib17","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/JVI.77.8.4588-4596.2003","article-title":"Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2","volume":"77","author":"Compton","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.kint.2021.04.016_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2010.01.043","article-title":"Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis","volume":"211","author":"van Leuven","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.kint.2021.04.016_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/S1413-86702006000200011","article-title":"Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?\u2014A mini-review","volume":"10","author":"Song","year":"2006","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.kint.2021.04.016_bib20","doi-asserted-by":"crossref","first-page":"27915","DOI":"10.1038\/srep27915","article-title":"Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling","volume":"6","author":"Rodrigues-Diez","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2021.04.016_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity\u2014what the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.016_bib22","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.2013060663","article-title":"Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients","volume":"25","author":"Ducloux","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.04.016_bib24","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/ATVBAHA.108.179713","article-title":"The discovery of cellular immunity in the atherosclerotic plaque","volume":"29","author":"Hansson","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2021.04.016_bib25","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2021.04.016_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","article-title":"Approaching the asymptote? Evolution and revolution in immunology","volume":"54","author":"Janeway","year":"1989","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.kint.2021.04.016_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.kint.2021.04.016_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cmi.2016.45","article-title":"Innate immunity and inflammation","volume":"14","author":"Xiao","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.kint.2021.04.016_bib29","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1111\/ajt.14012","article-title":"DAMP-induced allograft and tumor rejection: The circle is closing","volume":"16","author":"Land","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2021.04.016_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.trre.2015.04.001","article-title":"The diverging roles of dendritic cells in kidney allotransplantation","volume":"29","author":"Podest\u00e0","year":"2015","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.kint.2021.04.016_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2017.12.002","article-title":"Dendritic cells in the regulation of immunity and inflammation","volume":"35","author":"Quian","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.kint.2021.04.016_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cyto.2014.05.024","article-title":"Interleukin-6 and its receptors: a highly regulated and dynamic system","volume":"70","author":"Wolf","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.kint.2021.04.016_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coi.2015.02.008","article-title":"The IL-6\/gp130\/STAT3 signaling axis: recent advances towards specific inhibition","volume":"34","author":"Garbers","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.kint.2021.04.016_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1471-4906(01)02129-9","article-title":"Complement in inflammatory tissue damage and disease","volume":"23","author":"Molines","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.kint.2021.04.016_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.vph.2006.08.011","article-title":"The long pentraxin PTX3 in vascular pathology","volume":"45","author":"Mantovani","year":"2006","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.kint.2021.04.016_bib36","first-page":"295","article-title":"Pentraxin 3 and C-reactive protein as inflammatory markers after a kidney transplant","volume":"12","author":"Gursu","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.kint.2021.04.016_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/TP.0000000000001452","article-title":"Interleukin-6. A cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade","volume":"101","author":"Jordan","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2021.04.016_bib38","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2215\/CJN.00930209","article-title":"Inflammation in renal transplantation","volume":"4","author":"Abedini","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib39","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1096\/fj.02-0670fje","article-title":"Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans","volume":"17","author":"Starkie","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2021.04.016_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2021.04.016_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbi.2018.02.013","article-title":"Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters","volume":"70","author":"Del Giudice","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.kint.2021.04.016_bib42","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1042\/CS20170098","article-title":"Cytokines of the IL-1 family: recognized targets in chronic inflammation underrated in organ transplantations","volume":"131","author":"Striz","year":"2017","journal-title":"Clin Sci (London)"},{"key":"10.1016\/j.kint.2021.04.016_bib43","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1097\/TP.0000000000001548","article-title":"Inflammatory markers and outcomes in kidney transplant recipients","volume":"101","author":"Molnar","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2021.04.016_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/imt.15.1","article-title":"Novel insights into anti-CD40\/CD154 immunotherapy in transplant tolerance","volume":"7","author":"Pinelli","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.kint.2021.04.016_bib45","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa022600","article-title":"Soluble CD40 ligand in acute coronary syndromes","volume":"348","author":"Heeschen","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.04.016_bib46","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/3982","article-title":"Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes","volume":"4","author":"Hancock","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2021.04.016_bib47","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3389\/fimmu.2020.01807","article-title":"Coagulation and fibrinolysis in kidney graft rejection","volume":"11","author":"Stallone","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2021.04.016_bib48","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross-talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2021.04.016_bib49","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2021.04.016_bib50","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2174\/138161212799504731","article-title":"Inflammation-induced thrombosis: mechanisms, disease associations and management","volume":"18","author":"Aksu","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.kint.2021.04.016_bib51","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/ATVBAHA.112.248773","article-title":"Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in\u00a0vitro and in\u00a0vivo","volume":"32","author":"Martinez de Lizarrondo","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2021.04.016_bib52","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00395-013-0386-5","article-title":"CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction","volume":"108","author":"Hausding","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.kint.2021.04.016_bib53","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molmed.2008.09.006","article-title":"CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease","volume":"14","author":"Rizvi","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.kint.2021.04.016_bib54","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacc.2009.03.076","article-title":"The CD40\/CD40 ligand system: linking inflammation with atherothrombosis 2018","volume":"54","author":"Antoniades","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2021.04.016_bib55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12406","article-title":"Inflammation and plaque vulnerability","volume":"278","author":"Hansson","year":"2015","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.kint.2021.04.016_bib56","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/joim.12296","article-title":"Thrombosis formation on atherosclerotic lesions and plaque rupture","volume":"276","author":"Badimon","year":"2014","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.kint.2021.04.016_bib57","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1681\/ASN.2017121334","article-title":"Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: a meta-analysis","volume":"29","author":"Marthi","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib58","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1161\/STROKEAHA.115.010565","article-title":"Fibroblast growth factor 23 and incidence of subarachnoid hemorrhage: nested case-control study","volume":"46","author":"S\u00f6derholm","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.kint.2021.04.016_bib59","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and inflammation in CKD","volume":"7","author":"Mendoza","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib60","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000485472","article-title":"Associations of fibroblast growth factor 23 with markers of inflammation and leukocyte transmigration in chronic kidney disease","volume":"138","author":"Wallquist","year":"2018","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2021.04.016_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122885","article-title":"Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults","volume":"10","author":"Hanks","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.kint.2021.04.016_bib62","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.3390\/ijms20174195","article-title":"The role of fibroblast growth factor 23 in inflammation and anemia","volume":"20","author":"Czaya","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.kint.2021.04.016_bib63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fendo.2018.00320","article-title":"Role of fibroblast growth factor-23 in innate immune responses","volume":"9","author":"Fitzpatrick","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.kint.2021.04.016_bib64","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1159\/000495393","article-title":"Phosphate homeostasis, inflammation and the regulation of FGF-23","volume":"43","author":"Lang","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.kint.2021.04.016_bib65","doi-asserted-by":"crossref","first-page":"38108265","DOI":"10.1155\/2014\/381082","article-title":"Cardiovascular risk factors and chronic kidney disease FGF23: a key molecule in the cardiovascular disease","volume":"2014","author":"Jimbo","year":"2014","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.kint.2021.04.016_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000452880","article-title":"Klotho\/FGF23 axis in chronic kidney disease and cardiovascular disease","volume":"3","author":"Lu","year":"2017","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.kint.2021.04.016_bib67","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/ckj\/sfw065","article-title":"FGF23 is associated with early post-transplant hypophosphataemia and normalizes faster than iPTH in living donor renal transplant recipients: a longitudinal follow-up study","volume":"9","author":"Prasad","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2021.04.016_bib68","first-page":"1108","article-title":"Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23?","volume":"25","author":"Mazzaferro","year":"2012","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib69","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000509369","article-title":"The protective role of Klotho in CKD-associated cardiovascular disease","volume":"6","author":"Bi","year":"2020","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.kint.2021.04.016_bib70","first-page":"1834","article-title":"Serum Klotho in living kidney donors and kidney transplant recipients: a meta-analysis","volume":"9","author":"Thongprayoon","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.kint.2021.04.016_bib71","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrneph.2014.91","article-title":"Pattern recognition receptors and the inflammasome in kidney disease","volume":"10","author":"Leemans","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20171773","article-title":"The immunology of hypertension","volume":"215","author":"Norlander","year":"2018","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2021.04.016_bib73","doi-asserted-by":"crossref","first-page":"H1254","DOI":"10.1152\/ajpheart.00642.2019","article-title":"Adaptive immunity-driven inflammation and cardiovascular disease","volume":"317","author":"Ilatovskaya","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.kint.2021.04.016_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2017.10.003","article-title":"Inflammageing and metaflammation: the yin and yang of type 2 diabetes","volume":"41","author":"Prattichizzo","year":"2018","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.kint.2021.04.016_bib75","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaci.2020.08.013","article-title":"Regulating metabolic inflammation by nutritional modulation","volume":"146","author":"Charles-Messance","year":"2020","journal-title":"Allergy Clin Immunol"},{"key":"10.1016\/j.kint.2021.04.016_bib76","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3390\/molecules25092224","article-title":"Anti-inflammatory strategies targeting metaflammation in type 2 diabetes","volume":"25","author":"Kury\u0142owicz","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.kint.2021.04.016_bib77","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2020.09.004","article-title":"Lipid deposition and metaflammation in diabetic kidney disease","volume":"55","author":"Mitrofanova","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.kint.2021.04.016_bib78","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11892-013-0375-y","article-title":"Diabetes mellitus and inflammation","volume":"13","author":"Lontchi-Yimagou","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.kint.2021.04.016_bib79","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1348-0421.2009.00203.x","article-title":"Plasma lipoproteins are important components of the immune system","volume":"54","author":"Han","year":"2010","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.kint.2021.04.016_bib80","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/ATVBAHA.119.313224","article-title":"Soluble uric acid promotes atherosclerosis via AMPK (AMP-activated protein kinase)-mediated inflammation","volume":"40","author":"Kimura","year":"2020","journal-title":"Artherioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2021.04.016_bib81","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.kint.2020.05.056","article-title":"Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease","volume":"98","author":"Ponticelli","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib82","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ki.2015.89","article-title":"Inflammation and hypoxia in the kidney: friends or foes?","volume":"88","author":"Haase","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib83","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ki.2015.21","article-title":"Inflammation and hypoxia linked to renal injury by CCAAT\/enhancer-binding protein","volume":"88","author":"Yamaguchi","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"Hypoxia signaling in human diseases and therapeutic targets","volume":"51","author":"Lee","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.kint.2021.04.016_bib85","first-page":"3810","article-title":"Hypoxia promotes fibrogenesis in\u00a0vivo via HIF-1 stimulation of epithelial to mesenchymal transition","volume":"117","author":"Higgins","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2021.04.016_bib86","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib87","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1523-1755.2002.00439.x","article-title":"Interleukin-1beta as a mediator of tubulointerstitial fibrosis","volume":"62","author":"Burns","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib88","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1523-1755.2002.00401.x","article-title":"Interleukin-1 beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production","volume":"62","author":"Vesey","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib89","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2018.02.026","article-title":"Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease","volume":"94","author":"Durlacher-Betzer","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib90","first-page":"174","article-title":"FGF23 promotes renal interstitial fibrosis by activating beta-catenin","volume":"22","author":"Zhu","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.kint.2021.04.016_bib91","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1681\/ASN.V1261173","article-title":"Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes","volume":"12","author":"Vielhauer","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib92","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jcmm.13060","article-title":"Signalling pathways involved in hypoxia-induced renal fibrosis","volume":"21","author":"Liu","year":"2017","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.kint.2021.04.016_bib93","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","article-title":"Connective tissue growth factor is a mediator of angiotensin ii\u2013induced fibrosis","volume":"108","author":"Ruperez","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2021.04.016_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","article-title":"Uric acid as a danger signal in gout and its comorbidities","volume":"9","author":"Rock","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.kint.2021.04.016_bib95","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/ndt\/gfv024","article-title":"Hyperuricemia-induced inflammasome and kidney diseases","volume":"31","author":"Isaka","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.016_bib96","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41440-020-0481-6","article-title":"Uric acid and hypertension","volume":"43","author":"Lanaspa","year":"2020","journal-title":"Hypertens Res"},{"key":"10.1016\/j.kint.2021.04.016_bib97","doi-asserted-by":"crossref","first-page":"F336","DOI":"10.1152\/ajprenal.00053.2010","article-title":"Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells","volume":"299","author":"Yang","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2021.04.016_bib98","doi-asserted-by":"crossref","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","article-title":"Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease","volume":"304","author":"Ryu","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2021.04.016_bib99","first-page":"603","article-title":"Lipotoxicity as a trigger factor of renal disease","volume":"29","author":"Izquierdo-Lahuerta","year":"2016","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/1573399810666141122210135","article-title":"The relationship between inflammation, dyslipidemia and physical exercise: from the epidemiological to molecular approach","volume":"10","author":"Lira","year":"2014","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.kint.2021.04.016_bib101","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clnu.2004.08.004","article-title":"Dyslipidemia and inflammation: an evolutionary conserved mechanism","volume":"24","author":"Esteve","year":"2005","journal-title":"Clin Nutr"},{"key":"10.1016\/j.kint.2021.04.016_bib102","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/370341a0","article-title":"Mechanism of activation of the TGF beta receptor","volume":"370","author":"Wrana","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.kint.2021.04.016_bib103","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.cellsig.2013.06.001","article-title":"Transforming growth factor-b signalling: role and consequences of Smad linker region phosphorylation","volume":"25","author":"Kamato","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.kint.2021.04.016_bib104","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ki.1992.81","article-title":"TGF-\u03b2: regulation of extracellular matrix","volume":"41","author":"Roberts","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib105","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nm.3901","article-title":"Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease","volume":"21","author":"Grande","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2021.04.016_bib106","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/2319-4170.117622","article-title":"Chronic allograft dysfunction: a model disorder of innate immunity","volume":"36","author":"Land","year":"2013","journal-title":"Biomed J"},{"key":"10.1016\/j.kint.2021.04.016_bib107","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/ajt.15862","article-title":"Inflammation in areas of fibrosis: the DeKAF prospective cohort","volume":"20","author":"Matas","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2021.04.016_bib108","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/ajt.12210","article-title":"Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation","volume":"13","author":"Cavaill\u00e9-Coll","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2021.04.016_bib109","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1492-7535.2004.01085.x","article-title":"Inflammation as a cause of malnutrition, atherosclerotic, cardiovascular disease and poor outcome in hemodialysis patients","volume":"29","author":"Ya","year":"2004","journal-title":"Hemodial Int"},{"key":"10.1016\/j.kint.2021.04.016_bib110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.semnephrol.2016.10.007","article-title":"Inflammation and peritoneal dialysis","volume":"37","author":"Li","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib111","article-title":"Train to lose: innate immune memory in metaflammation","author":"Charles-Messance","year":"2020","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.kint.2021.04.016_bib112","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ni.3780","article-title":"Regulation of inflammation by microbiota interactions with the host","volume":"18","author":"Blander","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2021.04.016_bib113","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.162.11.1286","article-title":"Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults","volume":"162","author":"Abramson","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.kint.2021.04.016_bib114","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1249\/MSS.0000000000001113","article-title":"Physical activity, sedentary behavior, and inflammatory and hemostatic markers in men","volume":"49","author":"Parsons","year":"2017","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.kint.2021.04.016_bib115","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.03340410","article-title":"Low physical activity and risk of cardiovascular and all-cause mortality in renal transplant recipients","volume":"6","author":"Zelle","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib116","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ndt\/gfaa038","article-title":"Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients","volume":"35","author":"Kang","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.016_bib117","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13287-017-0478-5","article-title":"The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury","volume":"8","author":"Ranghino","year":"2017","journal-title":"Stem Cell Ther"},{"key":"10.1016\/j.kint.2021.04.016_bib118","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jss.2012.01.012","article-title":"Protective effect of pioglitazone on renal ischemia-reperfusion injury in mice","volume":"178","author":"Hu","year":"2012","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.kint.2021.04.016_bib119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/path.2916","article-title":"Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia-reperfusion injury","volume":"225","author":"Hu","year":"2011","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.kint.2021.04.016_bib120","first-page":"E1475","article-title":"RGMb protects against acute kidney injury by inhibiting tubular cell necroptosis via an MLKL-dependent mechanism","volume":"115","author":"Liu","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.kint.2021.04.016_bib121","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1681\/ASN.2003090795","article-title":"A\u00a0novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition","volume":"16","author":"Yang","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib122","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1111\/jcmm.14285","article-title":"Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation","volume":"23","author":"Zheng","year":"2019","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.kint.2021.04.016_bib123","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.phymed.2017.03.003","article-title":"Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy","volume":"30","author":"Li","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.kint.2021.04.016_bib124","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3892\/mmr.2014.2323","article-title":"Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction","volume":"10","author":"Jiang","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.kint.2021.04.016_bib125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000340033","article-title":"Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure","volume":"36","author":"Therrien","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib126","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/CCM.0b013e3181cf6e78","article-title":"Donor pretreatment with carbamylated erythropoietin in a brain death model reduces inflammation more effectively than erythropoietin while preserving renal function","volume":"38","author":"Nijboer","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.kint.2021.04.016_bib127","doi-asserted-by":"crossref","first-page":"F993","DOI":"10.1152\/ajprenal.00637.2014","article-title":"Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy","volume":"308","author":"Kim","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2021.04.016_bib128","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s10753-017-0610-9","article-title":"Adipose tissue inflammation and oxidative stress: the ameliorative effect of vitamin D","volume":"40","author":"Farhangi","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.kint.2021.04.016_bib129","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.ajkd.2016.01.019","article-title":"Aspirin use and incident cardiovascular disease, kidney failure, and death in stable kidney transplant recipients: a post hoc analysis of the folic acid for vascular outcome reduction in transplantation (FAVORIT) trial","volume":"68","author":"Dad","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.016_bib130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.0000025419.95769.F0","article-title":"Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy","volume":"106","author":"Cipollone","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2021.04.016_bib131","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2008.12.010","article-title":"Prevalence of low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study","volume":"53","author":"Michos","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2021.04.016_bib132","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00001721-200408000-00004","article-title":"Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patients","volume":"15","author":"Malyszko","year":"2004","journal-title":"Blood Coagul Fibrinolyis"},{"key":"10.1016\/j.kint.2021.04.016_bib133","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/ndt\/gfy159","article-title":"Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; a post hoc analysis of the PLANET trials","volume":"34","author":"Idzerda","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.016_bib134","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.04.016_bib135","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.kint.2017.09.011","article-title":"Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation","volume":"93","author":"Storey","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib136","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.016_bib137","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group","volume":"334","author":"Maschio","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.04.016_bib138","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(98)04433-X","article-title":"Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril efficacy in nephropathy","volume":"352","author":"Ruggenenti","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2021.04.016_bib139","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence","volume":"7","author":"Hiremath","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2021.04.016_bib140","first-page":"291","article-title":"The effect of renin-angiotensin system inhibitors on kidney allograft survival: a systematic review and meta-analysis","volume":"8","author":"Cheungpasitporn","year":"2016","journal-title":"N\u00a0Am J Med Sci"},{"key":"10.1016\/j.kint.2021.04.016_bib141","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","article-title":"Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials","volume":"69","author":"Hiremath","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.016_bib142","first-page":"155","article-title":"Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment","volume":"30","author":"Ponticelli","year":"2017","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2021.04.016_bib143","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.04.016_bib144","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","article-title":"Serum urate lowering with allopurinol and kidney function in type 1 diabetes","volume":"382","author":"Doria","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.04.016_bib145","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.04.016_bib146","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N\u00a0Engl J Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253821004543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253821004543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:00:06Z","timestamp":1758762006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253821004543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":146,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0085253821004543"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2021.04.016","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2021.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}